The AJCC staging is based on three main characteristics defining the natural history of melanoma; namely the extent of the primary tumor (T), the absence or presence of regional lymph node metastasis ...
Rational use of adjuvant anti-PD-1: Multi-omics model of recurrence in stage III melanoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full ...
Importantly, risk stratification showed the nomogram's ability to distinguish high- and low-risk patients more effectively than AJCC staging. Beyond clinical modeling, the study's genetic analysis ...
[18F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer Prognostic staging after neoadjuvant chemotherapy (NACT) is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results